Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : LastShadow's Position Trading -- Ignore unavailable to you. Want to Upgrade?

To: Susan Saline who wrote (6391)	1/14/1999 1:03:00 PM
From: rob108	Read Replies (1) \| Respond to of 43080

I'll check the news.(didn't know about it) I'm sticking this out, given my entry pt. What else are you speculating on this week? R.

To: Susan Saline who wrote (6391)	1/14/1999 1:14:00 PM
From: Mao II	Read Replies (1) \| Respond to of 43080

ENMD News Part of jump in ENMD may be related to imminent start of clinical tests on humans. (The time table is not news, but prospects are here and now.) aomc.org globalchange.com "....Endostatin and angiostatin - impressive cure rates in mice with wide variety of cancer growths. Effects in humans unknown but trials to start end 1998 - by Dr Judah Folkman using drugs made at the National Cancer Institute facility. Only for those who are desperately ill. Not enough drug supply to treat more than a handful. It will take till mid 1999 before production is enough for large scale trials." M2